Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Lorazepam Actavis
Lorazepam 1mg
Tablet
Actavis New Zealand Limited
Centaur Pharmaceuticals Private Limited, Maharashtra, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Nicabate Lozenge
Nicotine polacrilex 10mg equivalent to Nicotine 2mg
Lozenge
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Consumer Healthcare LP, South Carolina, United States of America
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Nicabate Lozenge
Nicotine polacrilex 20mg equivalent to Nicotine 4mg
Lozenge
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Consumer Healthcare LP, South Carolina, United States of America
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Zoledronic Acid
Zoledronic acid monohydrate 0.8528mg/mL equivalent to Zoledronic acid 0.8 mg/mL
Concentrate for infusion
InterPharma (NZ) Limited
Lisapharma SpA, Erba, Italy
|
Dated this 29th day of May 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz